Document Detail


PTEN modulators: a patent review.
MedLine Citation:
PMID:  23379765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: PTEN (phosphatase and tensin homolog deleted on chromosome 10) plays a pivotal role in controlling intracellular signaling for cell survival and proliferation by inhibiting the PI3K/Akt pathway, and its dysfunction is associated with several neoplastic diseases. PTEN is frequently found mutated in many pathological conditions highlighting its importance in normal physiological function. Unlike several cellular proteins which are activated by phosphorylation, PTEN is inactivated upon phosphorylation by specific kinases which phosphorylate serine and threonine residues in its C-terminal region. Therefore, development of therapeutic agents that specifically target kinases and kinase-domain-containing proteins affecting PTEN would lead to the treatment of PTEN-related diseases.
AREAS COVERED: With increasing evidence on the role of PTEN in many human diseases, the present review focuses on the clinical relevance of PTEN with a comprehensive list of currently identified modulators of PTEN, and proposes potentially novel molecular targets which could aid in the development of drug candidates for the treatment of PTEN-related diseases such as cardiovascular diseases, diabetes, obesity, cancer, autism, Parkinson's and Alzheimer's diseases.
EXPERT OPINION: This review describes several target sites that could help in the development of novel drug candidates to regulate or restore the normal physiological functions of PTEN and are essential in the treatment of human diseases where PTEN plays a pivotal role.
Authors:
Chandra S Boosani; Devendra K Agrawal
Related Documents :
23424995 - Molecular mechanisms underlying the antiproliferative and antimigratory effects of fola...
7644515 - Cell-free activation of neutrophil nadph oxidase by a phosphatidic acid-regulated prote...
16676075 - Plasminogen activator inhibitor-1 potentiates lps-induced neutrophil activation through...
15245865 - Parabutoporin--an antibiotic peptide from scorpion venom--can both induce activation an...
21277645 - Erk phosphorylation predicts synergism between gemcitabine and the epidermal growth fac...
2892535 - Cyclic phosphorylation/dephosphorylation cascade in bovine brain coated vesicles.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2013-02-05
Journal Detail:
Title:  Expert opinion on therapeutic patents     Volume:  23     ISSN:  1744-7674     ISO Abbreviation:  Expert Opin Ther Pat     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-19     Completed Date:  2013-10-28     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  9516419     Medline TA:  Expert Opin Ther Pat     Country:  England    
Other Details:
Languages:  eng     Pagination:  569-80     Citation Subset:  IM    
Affiliation:
Creighton University School of Medicine, Department of Biomedical Sciences, Omaha, NE 68178, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Design*
Humans
Molecular Targeted Therapy*
PTEN Phosphohydrolase / drug effects*,  metabolism
Patents as Topic
Phosphorylation
Phosphotransferases / drug effects,  metabolism
Grant Support
ID/Acronym/Agency:
R01 HL090580/HL/NHLBI NIH HHS; R01 HL104516/HL/NHLBI NIH HHS; R01 HL112597/HL/NHLBI NIH HHS; R01HL090580/HL/NHLBI NIH HHS; R01HL104516/HL/NHLBI NIH HHS; R01HL112597/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
EC 2.7.-/Phosphotransferases; EC 3.1.3.67/PTEN Phosphohydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endovascular repair of a nearly fatal iliac artery injury after endoureterotomy.
Next Document:  Severe community-acquired pneumonia treated with ?-lactam-respiratory quinolone vs. ?-lactam-macroli...